ArticleThe Journal of allergy and clinical immunology2017

Blocking Bcl-2 resolves IL-13-mediated mucous cell hyperplasia in a Bik-dependent manner.

Hitendra S Chand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.